论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
miR-499a-5p 通过激活 Wnt/β-连环蛋白信号通路促进子宫平滑肌瘤细胞的增殖和迁移
Received 10 April 2025
Accepted for publication 15 July 2025
Published 21 July 2025 Volume 2025:17 Pages 2245—2253
DOI https://doi.org/10.2147/IJWH.S533729
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Vinay Kumar
Jingjing Ni, Yan Ma, Jianping Qiu
Department of Obstetrics and Gynecology, The Affiliated Suzhou Hospital of Nanjing Medical University (Suzhou Municipal Hospital), Suzhou, Jiangsu, 215000, People’s Republic of China
Correspondence: Jianping Qiu, Email 15722703657@163.com
Objective: This study aimed to investigate the functional role and underlying mechanism of miR-499a-5p in the progression of uterine leiomyoma (ULM).
Methods: Expression levels of miR-499a-5p were analyzed in ULM tissues and cells. Functional assays were conducted to evaluate the effects of miR-499a-5p knockdown or overexpression on cellular proliferation, migration, apoptosis, and cell cycle progression. The involvement of the Wnt/β-catenin signaling pathway was assessed using pathway-specific protein markers and lithium chloride (LiCl) as a chemical activator.
Results: miR-499a-5p was significantly upregulated in ULM tissues and cells. Its knockdown inhibited proliferation and migration, induced apoptosis, and caused cell cycle arrest at the G0/G1 phase. Additionally, downregulation of miR-499a-5p suppressed the activation of the Wnt/β-catenin pathway, an effect that was reversed by LiCl treatment.
Conclusion: miR-499a-5p facilitates the development of uterine leiomyoma by activating the Wnt/β-catenin signaling pathway. These findings suggest that miR-499a-5p may serve as a promising molecular biomarker and a potential therapeutic target for ULM management.
Keywords: miR-499a-5p, uterine leiomyoma, Wnt/β-catenin signaling pathway, proliferation, migration